Arnold & Porter LLP
Use of A33 antigens and JAM-IT
The present invention relates to compositions and methods of treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer.
Genentech, Inc.
A A A G A A C G G A A A A A C A A A A C G G A G C A A G G G G C C A A G A A G A A C A A
A61P A61P A61P G01N A61P A61P C12Q G01N G01N A61P A61P A61P A61P A61P C07K A61K A61P A61P A61P C07K G01N G01N A61P G01N C07K A61P A61P G01N G01N G01N G01N C07K C07K A61P A61P G01N A61P A61P G01N A61P A61P C12Q A61P A61P
inventional inventional inventional additional inventional inventional additional additional additional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional additional additional inventional inventional additional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional
Audrey Austin L. Mary A. Avi Sherman Menno William I. Daniel
Goddard Gurney Napier Ashkenazi Fong Van Lookeren Wood Tumas